Interestingly, the prediabetic patients, especially those with chronic kidney disease, started with the highest H-FABP levels (85.15 ng/mL) which then normalized at 5.52, resulting in the most substantial phase I-II difference (79.63 ng/mL). This evidence concerns the gene FABP3 and chronic kidney disease.